2 February 2012
The clawback tax is a highly debated topic. Although this particular mechanism is technical and should be aimed mainly at drug producers, it has become a matter of general interest through the multiple implications it may have on the entire healthcare system and perhaps on other sectors - which could impose such a tax to other economic operators.
Read the article on Capital.ro (Author Sorin Popescu, ARPIM)
PricewaterhouseCoopers and D&B David si Baias are not liable for the title of this article, this being a direct copy of the title from the mentioned newspaper / publication.
